CompletedPhase 3NCT00093470
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Selina LugerECOG-ACRIN Cancer Research Group
- Intervention
- Clinical Observation(procedure)
- Enrollment
- 144 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2004
Study locations (30)
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- Providence Alaska Medical Center, Anchorage, Alaska, United States
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States
- Kaiser Permanente-San Diego Mission, San Diego, California, United States
- The Medical Center of Aurora, Aurora, Colorado, United States
- Boulder Community Hospital, Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States
- Porter Adventist Hospital, Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States
- SCL Health Saint Joseph Hospital, Denver, Colorado, United States
- Rose Medical Center, Denver, Colorado, United States
- Colorado Cancer Research Program NCORP, Denver, Colorado, United States
- Swedish Medical Center, Englewood, Colorado, United States
- Poudre Valley Hospital, Fort Collins, Colorado, United States
- Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00093470 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.